| 1 |
Prevention of recurrent ulceration of livedoid vasculopathy with long-term apixaban monotherapy. ( 30156315
)
|
Osada SI...Manabe M
|
2019 |
| 2 |
Topical becaplermin gel is an effective adjuvant for long-standing ulcers of livedoid vasculopathy recalcitrant to anticoagulant therapy. ( 30706539
)
|
Mushtaq S...Mudugal R
|
2019 |
| 3 |
Chronic leg ulcerations associated with livedoid vasculopathy successfully treated with rivaroxaban. ( 30767258
)
|
Miguel D...Goetze S
|
2019 |
| 4 |
Endovenous Laser Ablation Treatment for Lower Extremity Ulcers Associated With Livedoid Vasculopathy. ( 30882502
)
|
Chow M...Wysong A
|
2019 |
| 5 |
Characteristics, risk factors, and treatment reality in livedoid vasculopathy - a multi-centre analysis. ( 31009111
)
|
Weishaupt C...Goerge T
|
2019 |
| 6 |
Livedoid vasculopathy in a patient with bullous pemphigoid and primary Sjögren's syndrome. ( 29526676
)
|
Garc?a Briz MI...Mateu Puchades A
|
2018 |
| 7 |
Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin. ( 30455888
)
|
Yoshioka K...Chen KR
|
2018 |
| 8 |
Systemic Lupus Erythematosus Presenting as Livedoid Vasculopathy over the Forearms. ( 29911533
)
|
Yadav P...Singh D
|
2018 |
| 9 |
Livedoid Vasculopathy Presenting in a Patient With Sickle Cell Disease. ( 29533274
)
|
Reagin H...Susa J
|
2018 |
| 10 |
Treatment of Livedoid Vasculopathy With Rivaroxaban: A Potential Use of New Oral Anticoagulants for Dermatologists. ( 29074145
)
|
Jim?nez-Gallo D...Linares-Barrios M
|
2018 |
| 11 |
Treatment for Livedoid Vasculopathy: A Systematic Review. ( 29141075
)
|
Micieli R...Alavi A
|
2018 |
| 12 |
The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban. ( 29663354
)
|
Franco Marques G...Cajas Garc?a MS
|
2018 |
| 13 |
Livedoid Vasculopathy: A French Observational Study Including Therapeutic Options. ( 29738044
)
|
Gardette E...Barete S
|
2018 |
| 14 |
Ulcerative livedoid vasculopathy responding to clopidogrel. ( 29892667
)
|
Kunzler E...Chong BF
|
2018 |
| 15 |
Traditional Korean medicine treatment for livedoid vasculopathy: Five case reports. ( 30100128
)
|
Lee JA...Park S
|
2018 |
| 16 |
Livedoid vasculopathy: a compelling diagnosis. ( 30101138
)
|
Freitas TQ...Criado PR
|
2018 |
| 17 |
Dermoscopy of early non-ulcerated livedoid vasculopathy. ( 30244265
)
|
Wollina U
|
2018 |
| 18 |
Analysis of the German DRG data for livedoid vasculopathy and calciphylaxis. ( 28252815
)
|
Renner R...Erfurt-Berge C
|
2017 |
| 19 |
Livedoid vasculopathy and popliteal artery occlusion in a patient with protein S deficiency. ( 27774697
)
|
Nakayama T...Watanabe D
|
2017 |
| 20 |
Rapid remission of severe pain from livedoid vasculopathy by apixaban. ( 27166520
)
|
Yamaguchi Y...Shimizu H
|
2017 |
| 21 |
Dabigatran in the management of livedoid vasculopathy. ( 28052437
)
|
Sawada T...Suehiro M
|
2017 |
| 22 |
Enhanced mRNA expression of plasminogen activator inhibitor-1 in livedoid vasculopathy lesions. ( 28186689
)
|
Agirbasli M...Akkiprik M
|
2017 |
| 23 |
Fast Cicatrization of Extensive Livedoid Vasculopathy Ulcers under Treatment with Sildenafil. ( 28223767
)
|
Lopes LM...Bredemeier M
|
2017 |
| 24 |
Dermoscopic features of livedoid vasculopathy. ( 28296736
)
|
Hu SC...Lin YS
|
2017 |
| 25 |
Treatment application of rivaroxaban in Chinese patients with livedoid vasculopathy. ( 28360530
)
|
Chen W...Deng X
|
2017 |
| 26 |
|
Zampeli E...Moutsopoulos HM
|
2017 |
| 27 |
Prevention of livedoid vasculopathy recurrence by prolonged administration of rivaroxaban. ( 28609556
)
|
Drerup C...Goerge T
|
2017 |
| 28 |
Efficacy of new low-dose oral anticoagulants in recalcitrant livedoid vasculopathy. ( 28739563
)
|
Furukawa F...Shimizu T
|
2017 |
| 29 |
Analysis of serum levels and cutaneous expression of lipoprotein (a) in 38 patients with livedoid vasculopathy. ( 28901563
)
|
Espinel DPGS...Criado PR
|
2017 |
| 30 |
Use of Low-dose Oral Warfarin in Three Cases of Livedoid Vasculopathy. ( 28979014
)
|
Saoji V...Madke B
|
2017 |
| 31 |
Cilostazol: A novel agent in recalcitrant livedoid vasculopathy. ( 26345653
)
|
Mendiratta V...Nangia A
|
2016 |
| 32 |
Livedoid Vasculopathy Associated with HIV Infection in Two Patients: A Causal Relationship? ( 26778817
)
|
Hurabielle C...Barete S
|
2016 |
| 33 |
New hope for patients with livedoid vasculopathy. ( 26853641
)
|
Kirsner RS
|
2016 |
| 34 |
Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial. ( 26853646
)
|
Weishaupt C...Goerge T
|
2016 |
| 35 |
|
Provenza JR...Provenza GM
|
2016 |
| 36 |
Case series of recalcitrant livedoid vasculopathy treated with rivaroxaban. ( 26993107
)
|
Lee JM...Kim IH
|
2016 |
| 37 |
Recalcitrant Livedoid Vasculopathy Associated with Hyperhomocysteinaemia Responding to Folic Acid and Vitamins B6/B12 Supplementation. ( 27001413
)
|
Errichetti E...Stinco G
|
2016 |
| 38 |
Livedoid vasculopathy - a challenging disease. ( 27155327
)
|
Vieira R...Costa L
|
2016 |
| 39 |
Livedoid vasculopathy: A review of pathogenesis and principles of management. ( 27297279
)
|
Vasudevan B...Verma R
|
2016 |
| 40 |
|
Provenza JR...Provenza GM
|
2016 |
| 41 |
Successful Treatment of Livedoid Vasculitis with Primary Antiphospholipid Syndrome by Using Aspirin and Low Dose Warfarin Combination Therapy. ( 26512179
)
|
So BJ...Son SW
|
2015 |
| 42 |
Mononeuritis multiplex associated with primary livedoid vasculopathy: neuropathological evidence of ischemic nerve damage. ( 25798525
)
|
Malaguti MC...Morini A
|
2015 |
| 43 |
Therapeutic effect of autologous platelet-rich plasma (PRP) on recalcitrant cutaneous ulcers in livedoid vasculopathy. ( 27051763
)
|
Kawakami T...Soma Y
|
2015 |
| 44 |
Livedoid Vasculopathy with Hyperhomocysteinemia Responding to Hyperbaric Oxygen Therapy. ( 26538741
)
|
Ray R...Mohanty CS
|
2015 |
| 45 |
Sensory ganglionopathy with livedoid vasculopathy controlled by immunotherapy. ( 25196820
)
|
Alix JJ...Rao DG
|
2015 |
| 46 |
Response of livedoid vasculopathy to rivaroxaban. ( 25255997
)
|
Winchester DS...Davis MD
|
2015 |
| 47 |
Livedoid vasculopathy and high levels of lipoprotein (a): response to danazol. ( 25824252
)
|
Criado PR...Kirsner RS
|
2015 |
| 48 |
Pulsed intravenous immunoglobulin therapy in refractory ulcerated livedoid vasculopathy: seven cases and a literature review. ( 25845419
)
|
Kim EJ...Cho S
|
2015 |
| 49 |
Expanding the spectrum of livedoid vasculopathy: peculiar neuromuscular manifestations. ( 25871345
)
|
Allenbach Y...Benveniste O
|
2015 |
| 50 |
Lipoprotein(a) and livedoid vasculopathy: A new thrombophilic factor? ( 26328479
)
|
Criado PR...Sotto MN
|
2015 |
